Summit Therapeutics (SMMT) News Today → They said crypto was dead. It went up 100X. (From InvestorPlace) (Ad) Free SMMT Stock Alerts $4.12 -0.50 (-10.83%) (As of 03/18/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineSummit Therapeutics (NASDAQ:SMMT) Shares Gap Down to $4.62marketbeat.com - March 18 at 11:24 AMSummit Therapeutics Inc. (NASDAQ:SMMT) Short Interest Up 25.1% in Februarymarketbeat.com - March 14 at 11:38 PMIntracranial Anti-Tumor Activity and Safety of Ivonescimab in NSCLC Patients with Brain Metastases to be Featured at ELCC 2024businesswire.com - March 14 at 7:00 AMSummit Therapeutics (NASDAQ:SMMT) Stock Price Up 8.1%marketbeat.com - March 13 at 1:51 PMSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Summit Therapeutics Inc. - SMMTprnewswire.com - March 11 at 6:05 PMSummit Therapeutics (NASDAQ:SMMT) Shares Up 6.7%marketbeat.com - March 5 at 3:17 PMSummit Therapeutics to Present at the Barclays 26th Annual Global Healthcare Conferencebusinesswire.com - March 5 at 7:00 AMSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Summit Therapeutics Inc. - SMMTprnewswire.com - March 3 at 10:15 AMSHAREHOLDER ALERT: Potential Recovery for Summit Therapeutics Inc. (SMMT) Investorsmsn.com - February 27 at 9:26 AMSummit Therapeutics (NASDAQ:SMMT) Shares Gap Down to $4.64marketbeat.com - February 26 at 11:28 AMSummit Therapeutics Inc. (SMMT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoingsbusinesswire.com - February 26 at 4:00 AMSummit Therapeutics plc (SMMT)uk.finance.yahoo.com - February 21 at 9:21 AMQ4 2023 Summit Therapeutics Inc Earnings Callfinance.yahoo.com - February 21 at 9:21 AMSummit Therapeutics Inc. (NASDAQ:SMMT) Q4 2023 Earnings Call Transcriptfinance.yahoo.com - February 21 at 9:21 AMSummit Therapeutics (NASDAQ:SMMT) Shares Gap Down to $5.07marketbeat.com - February 20 at 11:34 AMSummit Therapeutics Reports Financial Results and Operational Progress for the Fourth Quarter and Year Ended December 31, 2023finance.yahoo.com - February 20 at 10:02 AMSummit Therapeutics Inc (SMMT) Reports Comprehensive 2023 Financial Results and Clinical ...finance.yahoo.com - February 20 at 10:02 AMSummit Therapeutics Reports Financial Results and Operational Progress for the Fourth Quarter and Year Ended December 31, 2023businesswire.com - February 20 at 7:00 AMSMMT Apr 2024 3.000 callfinance.yahoo.com - February 17 at 12:13 AMSMMT Mar 2024 4.000 putfinance.yahoo.com - February 17 at 12:13 AMSummit Therapeutics (NASDAQ:SMMT) Reaches New 52-Week High at $4.87marketbeat.com - February 16 at 10:53 AMSummit Therapeutics to Host Fourth Quarter & Full Year 2023 Financial Results & Operational Progress Call on February 20, 2024businesswire.com - February 14 at 10:29 AMSummit Therapeutics to Host Fourth Quarter & Full Year 2023finance.yahoo.com - February 14 at 10:18 AMSummit Therapeutics to Host Fourth Quarter & Full Year 2023businesswire.com - February 14 at 7:00 AMSummit Therapeutics (NASDAQ:SMMT) Stock Price Down 6.7%marketbeat.com - February 5 at 1:58 PMSummit Therapeutics (NASDAQ:SMMT) Shares Up 6.1%marketbeat.com - January 31 at 12:44 PMSummit Therapeutics: A Strategic Analysis Of Ivonescimab's Progressseekingalpha.com - January 30 at 8:39 AMSummit Therapeutics Announces Updated Phase II Data for Ivonescimab at 42nd Annual J.P. Morgan Healthcare Conferencefinance.yahoo.com - January 8 at 10:26 AMSummit Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conferencefinance.yahoo.com - January 3 at 9:43 AMSummit Therapeutics (NASDAQ:SMMT) Shares Up 15% on Insider Buying Activitymarketbeat.com - December 14 at 12:30 PMSummit Therapeutics Inc. (NASDAQ:SMMT) CEO Acquires $10,350.00 in Stockmarketbeat.com - December 13 at 7:25 PMSummit Therapeutics Reports Financial Results and Operational Progress for the Third Quarter and Nine Months Ended September 30, 2023finance.yahoo.com - November 7 at 9:24 AMSummit Therapeutics Inc (SMMT) Reports Q3 Financial Results and Operational Progressfinance.yahoo.com - November 7 at 9:24 AMIvonescimab's Novel Mechanism of Action Highlighting Cooperative Binding to be Featured in Poster Presentation at SITC 2023finance.yahoo.com - November 2 at 10:01 AMFormer Reata Pharmaceuticals CFO steps into new role with California biotech companybizjournals.com - November 1 at 4:40 PMIvonescimab’s Novel Mechanism of Action Highlighting Cooperative Binding to be Featured in Poster Presentation at SITC 2023finance.yahoo.com - October 31 at 12:20 PMSummit Therapeutics to Host Q3 2023 Financial Results & Operational Progress Call on November 7, 2023finance.yahoo.com - October 26 at 9:55 AMH. Jack West, MD, Renowned Oncologist & Lung Cancer Expert, Joins Summit Therapeutics as Vice President of Clinical Developmentfinance.yahoo.com - October 19 at 8:23 AMInsider Buying: COO Manmeet Soni Acquires 2,976,190 Shares of Summit Therapeutics Incfinance.yahoo.com - October 17 at 1:20 AMSummit Therapeutics: Not For Retail Investorsmsn.com - September 26 at 6:51 PMNavigating Summit Therapeutics' Bispecific Bet Amid Cash Constraintsseekingalpha.com - September 25 at 12:04 AMBaker BROS. Advisors LP Grows Position in Summit Therapeutics Inc. (NASDAQ:SMMT)marketbeat.com - September 12 at 5:40 AMBarclays PLC Grows Stock Holdings in Summit Therapeutics Inc. (NASDAQ:SMMT)marketbeat.com - August 29 at 4:14 AMQ2 2023 Summit Therapeutics Inc Earnings Callfinance.yahoo.com - August 9 at 11:15 PMSummit Therapeutics, Inc. (SMMT) Q2 2023 Earnings Call Transcriptseekingalpha.com - August 9 at 6:15 PMSummit Therapeutics Reports Financial Results and Operational Progress for the Second Quarter and Six Months Ended June 30, 2023finance.yahoo.com - August 9 at 8:14 AMSummit Therapeutics to Host Q2 2023 Financial Results & Operational Progress Call on August 9, 2023finance.yahoo.com - August 2 at 10:49 AMSummit Therapeutics Insiders Up US$558m On US$517m Investmentfinance.yahoo.com - July 11 at 12:49 PMPromising Data for Investigational Innovative Bispecific Ivonescimab Featured at ASCO 2023finance.yahoo.com - June 4 at 9:48 AMIvonescimab Updated Data to be Featured at ASCO 2023finance.yahoo.com - June 1 at 8:12 AM Get Summit Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for SMMT and its competitors with MarketBeat's FREE daily newsletter. Email Address Central Bank Gold Heist In Progress (Ad)When central banks buy gold… The rich buy right along with them. And central banks are buying at breakneck pace. Last year… 1,037 tons. Just 45 tons less than the record set two years ago. That's why we have released our Free Precious Metals Investment Guide. SMMT Media Mentions By Week SMMT Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SMMT News Sentiment▼0.470.63▲Average Medical News Sentiment SMMT News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SMMT Articles This Week▼51▲SMMT Articles Average Week Get Summit Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for SMMT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Arvinas News Today MoonLake Immunotherapeutics News Today Indivior News Today Crinetics Pharmaceuticals News Today IDEAYA Biosciences News Today Merus News Today Xenon Pharmaceuticals News Today Bausch Health Companies News Today Prestige Consumer Healthcare News Today TG Therapeutics News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SMMT) was last updated on 3/18/2024 by MarketBeat.com Staff From Our PartnersCentral Bank Gold Heist In ProgressColonial MetalsLike Tiny Crypto Retirement FundsCrypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyThe world’s greatest investmentPorter & CompanyForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingStock-Picking AI Predicts #1 Stock of 2024AltimetrySHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Summit Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.